annual CAPEX:
$34.28M-$27.93M(-44.90%)Summary
- As of today (May 29, 2025), ALNY annual capital expenditures is $34.28 million, with the most recent change of -$27.93 million (-44.90%) on December 31, 2024.
- During the last 3 years, ALNY annual CAPEX has fallen by -$42.09 million (-55.12%).
- ALNY annual CAPEX is now -75.54% below its all-time high of $140.16 million, reached on December 31, 2019.
Performance
ALNY CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$8.97M-$124.00K(-1.36%)Summary
- As of today (May 29, 2025), ALNY quarterly capital expenditures is $8.97 million, with the most recent change of -$124.00 thousand (-1.36%) on March 31, 2025.
- Over the past year, ALNY quarterly CAPEX has dropped by -$4.00 million (-30.86%).
- ALNY quarterly CAPEX is now -80.25% below its all-time high of $45.41 million, reached on September 30, 2018.
Performance
ALNY quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$30.27M-$4.00M(-11.68%)Summary
- As of today (May 29, 2025), ALNY TTM capital expenditures is $30.27 million, with the most recent change of -$4.00 million (-11.68%) on March 31, 2025.
- Over the past year, ALNY TTM CAPEX has dropped by -$31.02 million (-50.61%).
- ALNY TTM CAPEX is now -79.77% below its all-time high of $149.68 million, reached on March 31, 2019.
Performance
ALNY TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ALNY CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.9% | -30.9% | -50.6% |
| 3 y3 years | -55.1% | -49.8% | -60.7% |
| 5 y5 years | -75.5% | -54.3% | -73.8% |
ALNY CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -55.1% | at low | -58.5% | +114.0% | -63.0% | at low |
| 5 y | 5-year | -75.5% | at low | -65.6% | +114.0% | -73.8% | at low |
| alltime | all time | -75.5% | +2555.1% | -80.3% | >+9999.0% | -79.8% | +2245.0% |
ALNY CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $8.97M(-1.4%) | $30.27M(-11.7%) |
| Dec 2024 | $34.28M(-44.9%) | $9.09M(+116.9%) | $34.28M(-15.3%) |
| Sep 2024 | - | $4.19M(-47.7%) | $40.49M(-24.2%) |
| Jun 2024 | - | $8.02M(-38.2%) | $53.39M(-12.9%) |
| Mar 2024 | - | $12.97M(-15.3%) | $61.29M(-1.5%) |
| Dec 2023 | $62.21M(-13.7%) | $15.31M(-10.4%) | $62.21M(-9.2%) |
| Sep 2023 | - | $17.09M(+7.4%) | $68.54M(+0.9%) |
| Jun 2023 | - | $15.92M(+14.6%) | $67.95M(-0.2%) |
| Mar 2023 | - | $13.89M(-35.8%) | $68.09M(-5.5%) |
| Dec 2022 | $72.06M(-5.6%) | $21.64M(+31.0%) | $72.06M(-0.3%) |
| Sep 2022 | - | $16.51M(+2.8%) | $72.31M(-11.7%) |
| Jun 2022 | - | $16.05M(-10.1%) | $81.86M(+6.2%) |
| Mar 2022 | - | $17.86M(-18.4%) | $77.05M(+0.9%) |
| Dec 2021 | $76.37M(+8.5%) | $21.89M(-16.0%) | $76.37M(+0.3%) |
| Sep 2021 | - | $26.06M(+131.7%) | $76.15M(+21.8%) |
| Jun 2021 | - | $11.25M(-34.5%) | $62.51M(-8.0%) |
| Mar 2021 | - | $17.18M(-20.7%) | $67.92M(-3.5%) |
| Dec 2020 | $70.36M(-49.8%) | $21.67M(+74.5%) | $70.36M(-19.6%) |
| Sep 2020 | - | $12.42M(-25.5%) | $87.50M(-21.3%) |
| Jun 2020 | - | $16.66M(-15.1%) | $111.14M(-4.0%) |
| Mar 2020 | - | $19.62M(-49.4%) | $115.72M(-17.4%) |
| Dec 2019 | $140.16M(+10.5%) | $38.80M(+7.6%) | $140.16M(+0.9%) |
| Sep 2019 | - | $36.06M(+69.7%) | $138.86M(-6.3%) |
| Jun 2019 | - | $21.24M(-51.8%) | $148.22M(-1.0%) |
| Mar 2019 | - | $44.05M(+17.4%) | $149.68M(+18.0%) |
| Dec 2018 | $126.89M(+21.8%) | $37.51M(-17.4%) | $126.89M(+15.2%) |
| Sep 2018 | - | $45.41M(+100.0%) | $110.10M(+21.8%) |
| Jun 2018 | - | $22.71M(+6.8%) | $90.37M(+1.2%) |
| Mar 2018 | - | $21.26M(+2.6%) | $89.31M(-14.3%) |
| Dec 2017 | $104.21M(+61.4%) | $20.73M(-19.3%) | $104.21M(+0.8%) |
| Sep 2017 | - | $25.68M(+18.6%) | $103.36M(+5.5%) |
| Jun 2017 | - | $21.65M(-40.1%) | $97.98M(+10.2%) |
| Mar 2017 | - | $36.15M(+81.9%) | $88.89M(+37.7%) |
| Dec 2016 | $64.56M(+398.5%) | $19.88M(-2.1%) | $64.56M(+35.1%) |
| Sep 2016 | - | $20.30M(+61.6%) | $47.78M(+40.7%) |
| Jun 2016 | - | $12.56M(+6.3%) | $33.96M(+49.9%) |
| Mar 2016 | - | $11.82M(+281.3%) | $22.66M(+74.9%) |
| Dec 2015 | $12.95M(+44.5%) | $3.10M(-52.2%) | $12.95M(-3.2%) |
| Sep 2015 | - | $6.48M(+412.4%) | $13.38M(+32.5%) |
| Jun 2015 | - | $1.26M(-40.1%) | $10.10M(-5.5%) |
| Mar 2015 | - | $2.11M(-40.2%) | $10.68M(+19.2%) |
| Dec 2014 | $8.96M | $3.53M(+10.4%) | $8.96M(+41.9%) |
| Sep 2014 | - | $3.19M(+72.5%) | $6.31M(+55.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $1.85M(+377.3%) | $4.07M(+56.8%) |
| Mar 2014 | - | $388.00K(-55.8%) | $2.60M(-35.2%) |
| Dec 2013 | $4.01M(-52.0%) | $878.00K(-7.6%) | $4.01M(+5.0%) |
| Sep 2013 | - | $950.00K(+150.7%) | $3.81M(-55.6%) |
| Jun 2013 | - | $379.00K(-78.9%) | $8.59M(-13.1%) |
| Mar 2013 | - | $1.80M(+162.2%) | $9.88M(+18.4%) |
| Dec 2012 | $8.35M(+546.6%) | $686.00K(-88.0%) | $8.35M(+2.0%) |
| Sep 2012 | - | $5.73M(+243.1%) | $8.19M(+200.7%) |
| Jun 2012 | - | $1.67M(+535.0%) | $2.72M(+78.4%) |
| Mar 2012 | - | $263.00K(-49.8%) | $1.53M(+18.2%) |
| Dec 2011 | $1.29M(-72.7%) | $524.00K(+97.7%) | $1.29M(-32.2%) |
| Sep 2011 | - | $265.00K(-44.1%) | $1.91M(-29.6%) |
| Jun 2011 | - | $474.00K(+1592.9%) | $2.71M(-26.1%) |
| Mar 2011 | - | $28.00K(-97.5%) | $3.66M(-22.6%) |
| Dec 2010 | $4.73M(-4.4%) | $1.14M(+6.7%) | $4.73M(-2.6%) |
| Sep 2010 | - | $1.07M(-25.4%) | $4.86M(+7.3%) |
| Jun 2010 | - | $1.43M(+30.4%) | $4.53M(+8.8%) |
| Mar 2010 | - | $1.10M(-13.3%) | $4.16M(-15.9%) |
| Dec 2009 | $4.95M(-54.0%) | $1.26M(+71.6%) | $4.95M(-0.4%) |
| Sep 2009 | - | $737.00K(-30.6%) | $4.97M(-23.7%) |
| Jun 2009 | - | $1.06M(-43.7%) | $6.51M(-32.9%) |
| Mar 2009 | - | $1.89M(+46.8%) | $9.70M(-9.8%) |
| Dec 2008 | $10.76M(+38.2%) | $1.28M(-43.7%) | $10.76M(-21.5%) |
| Sep 2008 | - | $2.28M(-46.3%) | $13.71M(+13.0%) |
| Jun 2008 | - | $4.25M(+44.4%) | $12.14M(+29.4%) |
| Mar 2008 | - | $2.94M(-30.4%) | $9.38M(+20.4%) |
| Dec 2007 | $7.79M(+56.2%) | $4.23M(+500.6%) | $7.79M(+102.5%) |
| Sep 2007 | - | $705.00K(-52.8%) | $3.85M(-1.1%) |
| Jun 2007 | - | $1.50M(+10.4%) | $3.89M(-20.0%) |
| Mar 2007 | - | $1.35M(+365.3%) | $4.86M(-2.6%) |
| Dec 2006 | $4.99M(+156.1%) | $291.00K(-61.0%) | $4.99M(-5.8%) |
| Sep 2006 | - | $746.00K(-69.7%) | $5.29M(+7.6%) |
| Jun 2006 | - | $2.46M(+66.1%) | $4.92M(+74.3%) |
| Mar 2006 | - | $1.48M(+147.3%) | $2.82M(+45.0%) |
| Dec 2005 | $1.95M(-78.4%) | $600.00K(+61.3%) | $1.95M(-28.8%) |
| Sep 2005 | - | $372.00K(+1.1%) | $2.74M(-22.8%) |
| Jun 2005 | - | $368.00K(-39.4%) | $3.54M(-52.6%) |
| Mar 2005 | - | $607.00K(-56.3%) | $7.47M(-17.0%) |
| Dec 2004 | $9.01M(+188.7%) | $1.39M(+17.8%) | $9.01M(+18.2%) |
| Sep 2004 | - | $1.18M(-72.6%) | $7.62M(+18.3%) |
| Jun 2004 | - | $4.30M(+101.0%) | $6.44M(+201.0%) |
| Mar 2004 | - | $2.14M | $2.14M |
| Dec 2003 | $3.12M | - | - |
FAQ
- What is Alnylam Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual CAPEX year-on-year change?
- What is Alnylam Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Alnylam Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals TTM CAPEX year-on-year change?
What is Alnylam Pharmaceuticals annual capital expenditures?
The current annual CAPEX of ALNY is $34.28M
What is the all time high annual CAPEX for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual capital expenditures is $140.16M
What is Alnylam Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, ALNY annual capital expenditures has changed by -$27.93M (-44.90%)
What is Alnylam Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of ALNY is $8.97M
What is the all time high quarterly CAPEX for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly capital expenditures is $45.41M
What is Alnylam Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, ALNY quarterly capital expenditures has changed by -$4.00M (-30.86%)
What is Alnylam Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of ALNY is $30.27M
What is the all time high TTM CAPEX for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high TTM capital expenditures is $149.68M
What is Alnylam Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, ALNY TTM capital expenditures has changed by -$31.02M (-50.61%)